Chemed executive vice president Lee sells $494,196 in stock
At a glance
- $CHE today−0.49%last $546.75
- Vs industry peers+0.71 pts6-peer median −1.21% · ahead
- Since Nov 8+2.93%from the first trade after the story
- 52-week range2.8% below high$365.21 – $562.24
- In the headline$494,196Amount
- Coverage1 this week4 in 30 days · too few stories to call a pace
Nothing reported about chemed across key-person, legal, regulatory, security, operational or financial-integrity risk in three weeks of coverage and 30 days of SEC filings.
Ranges are one standard deviation of volatility around the latest close — about 1 week in 3 moves further. Not a forecast or investment advice.
What it means
- What to watch: The headline hangs on one number ($494,196) — one data point is a snapshot, so the trailing trend is the context it needs.
- How the stock is trading: $CHE -0.49% in the latest session.
- Timing: It was published over the weekend. The change shown is Friday's, and Monday is the first session that could react. Market holidays are not detected.
Where the stock stands
Chemed ($CHE) slipped 0.49% to $546.75 in the latest session. Over the past month it is up 7.6%. That leaves it 2.8% below its 52-week high of $562.24 and 50% above its low of $365.21, close to the top of its range. The high sits 54% above the low, a wide range for one year.
How much coverage it is getting
Wook has filed 4 stories on Chemed in the last 30 days, 1 of them this week. That is about its usual pace: over the month it has averaged about 1 a week. Going by their wording, 0 read bullish, 4 neutral and 0 bearish. This one reads neutral too, in line with most of them. Investing.com wrote 3 of the 4 (75%), so the count reflects one outlet's output more than broad attention.
The bigger picture
Healthcare stories turn on approvals, trial data and pricing: one FDA decision or trial readout can swing a single drugmaker hard, while drug-pricing policy moves the whole group at once.
What to watch next
For the company's side of it, read its latest SEC filings on the $CHE page. A US company has to report material news on an 8-K, usually within four business days; foreign issuers use a 6-K. Most of the recent coverage comes from one outlet, so check whether another newsroom has confirmed the story or is only repeating it. To run the numbers yourself, ask Wook AI above about $CHE: its distance from the high, its last report, or how coverage has changed.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Investing.com published this on November 8, 2026. $CHE has moved +2.93% ($531.21 to $546.75). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.
